Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Winfrey opened up about her decision to use a medication to help her lose weight in an interview with People. Her new TV ...

Oprah Winfrey admitted two years ago to taking diabetes medication to lose weight. Now, in a new podcast episode, she ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

the popular anti-diabetic drug. Usually prescribed to those with Type 2 diabetes, it is also used for weight loss. “I was not able to get the weight off myself,” McKoon said. She started ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...